Newsletter Archive

1. 04.27.26 -- The Importance Of Upstream–Downstream Coordination 4/27/2026
   04/27/26 Bioprocess Online Newsletter
2. 04.25.26 -- Balancing Legacy Systems With The Adoption Of New Technologies 4/25/2026
   04/25/26 Bioprocess Online Newsletter
3. 04.24.26 -- STREAM Edition: Biosimilars And Complex Medicines For All With RNA Therapeutics' Sarfaraz Niazi, Ph.D. 4/24/2026

   04/24/26 Bioprocess Online Newsletter

4. 04.24.26 -- Green Supply Chains Rarely Start With A Pledge; Target Waste Instead 4/24/2026
   04/24/26 Bioprocess Online Newsletter
5. 04.23.26 -- Quantifying Single-Use Waste Produced During mAb Manufacture 4/23/2026
   04/23/26 Bioprocess Online Newsletter
6. 04.22.26 -- Building Resilient Biomanufacturing From Media To Market 4/22/2026

   04/22/26 Bioprocess Online Newsletter

7. 04.22.26 -- Technological advances in biosafety testing which will de-risk and reduce your regulatory timelines 4/22/2026

   04/22/26 Bioprocess Online Newsletter

8. 04.22.26 -- Drug-Device Combination Products: 4 Evolving Platforms For 2026 4/22/2026
   04/22/26 Bioprocess Online Newsletter
9. 04.21.26 -- Where Bioprocess Automation Is Headed 4/21/2026

   04/21/26 Bioprocess Online Newsletter

10. 04.21.26 -- What If The U.S. Government Stopped Funding Biotech? 4/21/2026
    04/21/26 Bioprocess Online Newsletter